 | Up a level |
Leucht, Stefan; Schneider-Thoma, Johannes; Burschinski, Angelika; Peter, Natalie; Wang, Dongfang; Dong, Shimeng; Huhn, Maximilian; Nikolakopoulou, Adriani; Salanti, Georgia; Davis, John M (2023). Long-term efficacy of antipsychotic drugs in initially acutely ill adults with schizophrenia: systematic review and network meta-analysis. World psychiatry, 22(2), pp. 315-324. Masson Italy 10.1002/wps.21089
Burschinski, Angelika; Schneider-Thoma, Johannes; Chiocchia, Virginia; Schestag, Kristina; Wang, Dongfang; Siafis, Spyridon; Bighelli, Irene; Wu, Hui; Hansen, Wulf-Peter; Priller, Josef; Davis, John M; Salanti, Georgia; Leucht, Stefan (2023). Metabolic side effects in persons with schizophrenia during mid- to long-term treatment with antipsychotics: a network meta-analysis of randomized controlled trials. World psychiatry, 22(1), pp. 116-128. Masson Italy 10.1002/wps.21036
Bighelli, Irene; Rodolico, Alessandro; García-Mieres, Helena; Pitschel-Walz, Gabi; Hansen, Wulf-Peter; Schneider-Thoma, Johannes; Siafis, Spyridon; Wu, Hui; Wang, Dongfang; Salanti, Georgia; Furukawa, Toshi A; Barbui, Corrado; Leucht, Stefan (2021). Psychosocial and psychological interventions for relapse prevention in schizophrenia: a systematic review and network meta-analysis. The Lancet. Psychiatry, 8(11), pp. 969-980. Elsevier 10.1016/S2215-0366(21)00243-1
Schneider-Thoma, Johannes; Kapfhammer, Angelika; Wang, Dongfang; Bighelli, Irene; Siafis, Spyridon; Wu, Hui; Hansen, Wulf-Peter; Davis, John M; Salanti, Georgia; Leucht, Stefan (2021). Metabolic side effects of antipsychotic drugs in individuals with schizophrenia during medium- to long-term treatment: protocol for a systematic review and network meta-analysis of randomized controlled trials. Systematic Reviews, 10(1), p. 214. BioMed Central 10.1186/s13643-021-01760-z
